Kinases in Cancer: Advancing Targeted Therapies and Their Implications in Cancer Immunity

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".

Deadline for manuscript submissions: 30 March 2025 | Viewed by 82

Special Issue Editors


E-Mail Website
Guest Editor
Department of Molecular and Cellular Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: tyrosine kinase signaling; adapters and scaffolds in signal transductions; DNA damage response; inflammatory cancer signaling and immunity

E-Mail Website
Guest Editor
1. Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
2. Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA
Interests: structural biophysics; precision oncology; cancer bioinformatics; DNA replication; DNA repair

Special Issue Information

Dear Colleagues,

The phospho-modification of amino acids is a powerfully effective way to control cell-fate by dynamically altering protein function based upon environmental changes. Such modifications can act efficiently in response to stress by reversibly changing the local chemistry, forming and disrupting functional protein complexes, and activating signaling cascades. Thus, the human kinome encompasses one of the largest family of proteins that control all aspects of cellular processes from growth, proliferation, and survival to energy production and DNA replication and damage response. The deregulation of kinases themselves or of the adapters and scaffolds within the kinome axis that orchestrates signaling can lead to diseases including malignant transformation and cancer.

In this Special Issue, we will examine kinases and their function in normal and in disease signaling, particularly in cancers and related disorders. Kinases are the most drug-targeted protein family for cancer therapeutics. Yet, we are coming to better understand their regulations and targeting by adaptors and molecular machinery that provide underappreciated targeting opportunities. This Special Issue will therefore also address current information regarding successes, failures, and promising future strategies for kinase targeting. We aim to explore kinase interactome mechanisms, specific inhibitors/approved drugs, and therapeutic impacts on cancer inflammatory signaling extending to potential impact on cancer immunity.

Dr. Zamal Ahmed
Dr. John A. Tainer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • kinase targets
  • proliferation
  • cell cycle checkpoints
  • DNA damage responses
  • inflammation
  • cancer immune response
  • phosphatase targets
  • adaptor and scaffold targets

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop